Your feedback provides us with vital information that assists in the development of future educational initiatives.
Assessment of Learning Objectives

Using a scale of poor to excellent, please indicate your level of confidence in the learning objective as it relates to your knowledge, belief, or behavior, pre-program and post-program.

Question Title

Diabetes and Heart Failure: What must a diabetologist know?  | Shelley Zieroth, MD

Your knowledge of screening, diagnosis and management of heart failure in patients with diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Your knowledge of the new therapeutics (including SGLT2i) in the prevention and treatment of heart failure in patients with diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Effectiveness of Speaker:

Question Title

Additional comments:

Question Title

Obesity and Diabetes | Sean Wharton, MD

Your knowledge of non-pharmacologic and pharmacologic management of obesity in patients with diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Your knowledge of recommendations pertaining to bariatric surgery in patients with diabetes and obesity:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Effectiveness of Speaker:

Question Title

Additional comments:

Question Title

Decolonizing Diabetes Health Care | Randal Bell

Your knowledge of the prevalence of diabetes in Indigenous communities:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Your knowledge of the current systemic barriers to Indigenous health and diabetes management:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Your knowledge of strategies and initiatives to reduce the burden of diabetes in Indigenous people:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Effectiveness of Speaker:

Question Title

Additional comments:

Question Title

Update on Incretin Therapies | Alice Cheng, MD

Your knowledge of the evolution of the role of incretin therapies in the contemporary management of diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Your knowledge of the therapeutic potential and future applications of triple agonist therapy:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Effectiveness of Speaker:

Question Title

Additional comments:

Question Title

Nutrition and Diabetes | Michael Mindrum, MD

Your knowledge of current and evolving nutritional approaches for the prevention and management of diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Effectiveness of Speaker:

Question Title

Additional comments:

Question Title

Diabetes and Mental Health | Barry Simon, MD

Your knowledge of approaches for the screening and diagnosis of binge eating disorder and depression in patients with diabetes including specific screening tools:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Your knowledge of treatment interventions, both lifestyle and pharmacologic, for depression and binge eating disorder:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Effectiveness of Speaker:

Question Title

Additional comments:

Question Title

Diabetes and Chronic Kidney Disease | David Cherney, MDCM

Your knowledge of updates in recent evidence for therapies for diabetic kidney disease:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Your knowledge of current recommended management strategies for patients with diabetes and chronic kidney disease:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

Effectiveness of Speaker:

Question Title

Additional comments:

Additional Feedback 

Question Title

2. From what you have learned, how will this impact / modify your practice and what will you be able to apply to your practice? What potential barriers do you anticipate and how will you overcome them?

Question Title

Please indicate which CanMEDS roles you felt were addressed during this educational activity?

Question Title

Sessions allocated at least 25% of the time for interaction

Question Title

Did you perceive any sources of commercial bias in any of the sessions? If so, please explain:    

Question Title

Did the activity comply with the Code of Ethics for parties involved in continuing medical education?

Question Title

Were there any topics you think should have been addressed?  Any recommendations for future sessions?

Question Title

Please share any additional comments:

Thank you!

T